Drug Development Archives | 第 3 页，共 26 页 | Certara

On-Demand Webinar

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Investors, founders, and drug development strategists on what makes an early-stage biotech investable beyond the…

Certara2026 年 8 月 6 日

Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

Certara2026 年 7 月 29 日

Poster

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…

Certara2026 年 7 月 20 日

Conference

EANM 2026

–

Danielle Pillsbury2026 年 7 月 20 日

On-Demand Webinar

From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Learn how dosimetry, clinical pharmacology, pharmacometrics, QSP, and regulatory strategy support dose optimization for therapeutic…

Hunter Stephens, PhD2026 年 7 月 17 日

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

Certara2026 年 7 月 16 日

Publication

Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

Explore how population pharmacokinetic and exposure–response modeling informed brexpiprazole dosing in Japanese patients with agitation…

Certara2026 年 7 月 16 日

Webinar

Trusted Cheminformatics, Zero Integration Headaches: ML in Python with Chemaxon

Jan Christopherson2026 年 7 月 14 日

On-Demand Webinar

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

Certara2026 年 7 月 13 日

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

Zoe Barter2026 年 7 月 13 日

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software